ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $223 | -11.9% | 8,220 | 0.0% | 0.01% | -11.1% |
| Q2 2023 | $253 | -15.4% | 8,220 | -0.9% | 0.01% | -18.2% |
| Q1 2023 | $299 | -8.8% | 8,293 | 0.0% | 0.01% | -8.3% |
| Q4 2022 | $328 | -99.9% | 8,293 | +1.1% | 0.01% | 0.0% |
| Q3 2022 | $330,000 | -2.7% | 8,203 | +1.8% | 0.01% | -7.7% |
| Q2 2022 | $339,000 | +59.9% | 8,058 | +48.3% | 0.01% | +85.7% |
| Q1 2022 | $212,000 | +26.2% | 5,434 | +28.9% | 0.01% | +16.7% |
| Q4 2021 | $168,000 | +78.7% | 4,216 | +61.3% | 0.01% | +100.0% |
| Q3 2021 | $94,000 | -21.7% | 2,614 | -10.8% | 0.00% | -25.0% |
| Q2 2021 | $120,000 | – | 2,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |